the cryptocurrency market, Overview

Market News: A fire broke out at Kaliningrad Shipyard in Russia.Macao celebrated the 25th anniversary of its return to the motherland with the debut of the digital MOP prototype system. In order to celebrate the 25th anniversary of Macao's return to the motherland, the "Celebrating the Successful Construction of Digital MOP Prototype System and the Release of Digital MOP White Paper" hosted by the Macao Monetary Authority was held on December 12th. It is reported that the Macao SAR, with the support of the People's Bank of China, has successfully built a prototype system of digital patacas, laying the necessary foundation for the future development of digital patacas. In the future, digital Macao pataca, as the legal tender of Macao SAR, has the same legal status and value as paper money and coins, with 100% reserve support and full legal compensation; And interoperate with various existing electronic payment systems in the Macao Special Administrative Region to realize the interconnection between wallets of different operating institutions, digital MOP wallets and bank accounts, and create a more efficient and cost-effective trading environment. (CCTV News)According to Siemens, digital business revenue has more than doubled this year, reaching 1.7 billion euros, exceeding the commitment in 2021 ahead of schedule.

CITIC Securities: The resonance between supply and demand of medical beauty accelerates the space expansion, and the difference in operating ability promotes the evolution of the industry structure. CITIC Securities Research Report stated that the medical beauty industry has both medical and consumption attributes, and the medical attribute has strong product-driven characteristics, while the consumption attribute has high operating ability requirements. The medical beauty botulinum toxin track is also affected by the dual attributes of medicine and consumption: 1) The increase in penetration rate, the acceleration of compliance substitution and the extension of indications have brought about high demand for medical beauty botulinum toxin, and with the recent supply expansion, the industry scale has experienced high growth; 2) The iteration of product innovation is slow, brand barriers are created through marketing, doctors are empowered through direct sales, and control is strengthened to enhance product competitiveness. Recently, a variety of medical botulinum toxins in China have been approved, and the promotion of low-priced products is expected to push up the penetration rate, and enterprises with strong operational capabilities will enter the market or promote the evolution of the pattern.Shan Ying International: It is proposed to raise the share repurchase price ceiling to 3 yuan/share. Shan Ying International (600567) announced on the evening of December 12 that it intends to adjust the share repurchase price ceiling from 2.34 yuan/share to 3 yuan/share.Zhonggong Education: Director Yi Ziting resigned due to retirement. Zhonggong Education announced that the company's board of directors recently received a written resignation report from Director Yi Ziting. Yi Ziting applied to the company's board of directors for resignation due to retirement, and will not hold other positions in the company after resignation.

Piper Sandler lowered the target price of Adobe from 635.00 to 600.00.Laimei Pharmaceutical Co., Ltd.: The controlling shareholder intends to transfer 23.43% of the shares by agreement. Laimei Pharmaceutical announced that Zhongheng Group, the controlling shareholder, intends to transfer 247 million shares of the company's unrestricted tradable A shares by public solicitation of the transferee, accounting for 23.43% of the company's total share capital, and the transfer price is not less than 4.42 yuan/share. If the share transfer is completed, the controlling shareholder and actual controller of the company may change.Tiankang Bio: Tiankang Bio (002100) announced on the evening of December 12 that Tiankang Bio (stock code: 874339), a holding subsidiary of the company, intends to apply for public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange. As of the disclosure date of the announcement, Tiankang Bio's public offering of shares to unspecified qualified investors and listing on the North Stock Exchange are under counseling.